Engaging Shareholders in Meaningful Governance
Vistin Pharma ASA (OSE: VISTN) is gearing up for its highly anticipated Annual General Meeting, set to take place on May 22 at 1:00 PM CEST. The company recognizes the importance of shareholder involvement and is prioritizing accessibility in its governance process.
Proxy Vote Options for Shareholders
In an innovative approach, Vistin Pharma will not conduct a physical meeting. Instead, shareholders are encouraged to authorize the Chairman of the Board to represent their interests. This method allows for flexibility as shareholders can provide proxy votes with or without specific voting instructions. Utilizing a proxy with instructions will enable shareholders to influence decisions without the need for personal attendance, ensuring broader participation.
Maximizing Participation
By implementing this proxy voting system, Vistin Pharma ASA empowers its shareholders, making it easier than ever for them to have a voice in the company's direction. This approach demonstrates Vistin Pharma's commitment to fostering an inclusive governance environment, where shareholder opinions are valued and taken into account.
Detailed Information and Recommendations
Attached to the notice is the recommendation from the Election Committee, offering guidance on board selections and overall governance. This information aims to help shareholders make informed decisions, contributing to the effective management of the company. The formal notification will be sent to all shareholders registered in the Norwegian Central Security Depository (VPS) and is included in this announcement.
Access to Supporting Documents
Shareholders can find the necessary documentation on Vistin Pharma's website for a deeper understanding of the agenda and proposals that will be discussed during the meeting. The documentation includes the Company’s annual report, remuneration policy, and a detailed agenda for the meeting itself, showcasing the company's transparency and commitment to sharing pertinent information with shareholders.
Contact for Further Information
If you have any questions or require additional information regarding the meeting or proxy options, please reach out to:
Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com
Frequently Asked Questions
What is the date of the Annual General Meeting?
The Annual General Meeting for Vistin Pharma ASA is scheduled for May 22, 2025.
How can shareholders participate in the meeting?
Shareholders may authorize the Chairman of the Board and provide proxy votes with or without specific voting instructions to participate without attending in person.
What documents are available for shareholders?
Shareholders can access the notice, the Election Committee’s recommendation, and the annual report on Vistin Pharma's website.
Who should shareholders contact for queries?
For any questions, shareholders can contact CFO Alexander Karlsen at +47 97 05 36 21 or via email.
Why is the meeting being held in this format?
The virtual meeting format allows more flexibility for shareholders to participate and voice their opinions without being physically present.
